ABSTRACT We compared secular trends in ischemic heart disease (IHD) mortality in four southeastern states (North Carolina, Georgia, South Carolina, and Virginia) with those in three selected other states (California, New York, and Utah). Mortality data were obtained from U. S. vital statistics and population information from the U. S. Census Bureau. Age-adjusted IHD mortality increased until 1968 in the southeastern states and then declined and declines were greatest in the nonwhite female population. In contrast, IHD mortality in all groups in California and in the female population in New York and Utah began to decline in the early 1950s, with accelerated declines since 1968. In all states the decline in rates in nonwhite populations have been greatest in the younger age groups. This has not been true in the white populations. Declining IHD mortality correlated moderately well with the decline in death from all cardiovascular disease and from all causes, but not with the declining cerebrovascular disease mortality. Respiratory cancer mortality increased in similar proportions in California and South Carolina, two states with dissimilar IHD trends. These findings suggest that improved control of hypertension and changing patterns of cigarette smoking may not be responsible for the recent decline in IHD mortality. Circulation 68, No. 1, 3-8, 1983. THE WELL-PUBLICIZED recent decline in ischemic heart disease (IHD) mortality in this country and in several other western nationsl' has generated much speculation as to its underlying causes and has rekindled interest in the search for the etiology of IHD. Studies of geographic variations in disease-specific mortality have provided useful epidemiologic clues and might help to elucidate the reasons for the recent decline in IHD mortality.4
THE WELL-PUBLICIZED recent decline in ischemic heart disease (IHD) mortality in this country and in several other western nationsl' has generated much speculation as to its underlying causes and has rekindled interest in the search for the etiology of IHD. Studies of geographic variations in disease-specific mortality have provided useful epidemiologic clues and might help to elucidate the reasons for the recent decline in IHD mortality. 4 International studies of secular IHD mortality trends have shown marked geographic variability. While mortality has been declining in the United States, Canada, Australia, Finland, Belgium, and Israel, it has been increasing in Sweden, Denmark, Eastern Europe, and the Soviet Union.2' 7-9 Regional studies in the United States have demonstrated dramatic interstate and intercounty differences in IHD mortality, as well as a recent concentration of high rates in the southeastern United States. I'll However, no study of regional secular trends has been reported. In the last review of this subject, only data from the years up to and including 1971 were analyzed,14 and most of the decline has occurred since that time. ' The first purpose of our study was to examine regional differences in IHD mortality trends in the United States from 1950 to 1976. We also assessed the impact of changing IHD mortality on the rate of death from all cardiovascular disease (CVD) and on the rate of death from all causes. Our second purpose was to investigate some of the hypotheses concerning the reasons for the decline in IHD mortality by studying mortality trends in diseases that share risk factors with IHD. For example, hypertension is known to be a major risk factor for both cerebrovascular disease (CVA) and IHD'6 17 and cigarette smoking is a risk factor for both IHD and respiratory tract cancer."7 18 We studied trends in CVA and respiratory cancer mortality in an attempt to explore the potential contributions to the decline in IHD male populations in the three selected other states. In contrast to the trends seen in the Southeast, mortality rates declined in California before 1968 and were relatively constant in New York and Utah (figure 2). Since 1968, age-adjusted mortality rates declined in all three states.
The changes in age-adjusted rates between 1950 and 1967, and 1968 and 1976 (before and after the ICD coding change) are presented in table 1 for the four race-sex groups. In the Southeast, mortality increased for all groups from 1950 to 1967, with the greatest increases in the nonwhite male populations. In California, however, rates did not increase during this period and fairly substantial declines were evident in white male and female populations. Likewise, rates did not increase in New York (where there were definite declines in mortality in the female population) or in Utah over this time span. From 1968 to 1976, in all states there were declining mortality rates for each of the race-sex groups. For the southeastern states, this represents reversal of the trend of increasing mortality, There were dramatic declines in CVA mortality in the years from 1950 to 1976 for all race-sex groups in the seven states, with declines ranging from 39% to 73% (table 5). Figure 3 shows an interesting pattern in these various declines. Mortality rates for CVA were widely divergent in 1950 and were divided into two distinct groups (southeastern and other states), the rates in Virginia being the median rates. However, they converged to a more narrow range in 1976, with the southern states retaining their higher rates and with those for 4 . Respiratory cancer mortality increased similarly in both states until around 1968. Thereafter, rates in South Carolina increased rapidly, whereas those in California, the state that showed the earliest decline in incidence of IHD as well as a lower rate, increased only slightly.
Discussion
Regional variations in IHD mortality have often been used to suggest underlying causal factors for IHD. In 1950, high rates were found for white populations in the New England, Middle Atlantic, South Atlantic, Great Lakes, Mississippi delta, and Western regions of the United States. It was suggested that occupational, geographic, climatic, or geologic factors might be responsible for the observed differences. 10 hypertension, at least as indexed by CVA mortality, is a major contributing factor to the decline in the incidence ofIHD mortality. It is also known that control of hypertension is associated with a reduction in stroke mortality, but not necessarily in IHD mortality. 24 Respiratory tract cancer mortality increased similarly in California (a state in which there has been declining IHD mortality since the early 1950s) and South Carolina (in which there was increasing IHD mortality until after 1968). Cigarette smoking is a major risk factor for both diseases,'7 yet we observed no abatement in the rise in respiratory cancer mortality at a time when IHD mortality was declining. This suggests either that changes in tobacco use do not play a major role in the decline in IHD mortality or that a decline in cigarette consumption might be reflected in an IHD decline before being reflected in a downturn in respiratory cancer mortality. It is also known that smoking confers different degrees of risk for lung cancer and IHD; the relative risk for lung cancer among smokers as compared with nonsmokers is 13 whereas that for IHD is 2.4.17, 1 In summary, we have found that two diseases that share risk factors with IHD have "behaved" quite differently from IHD during the period from 1950 to 1976. It may be that the IHD decline is totally independent of any fundamental changes in the prevalence of hypertension or cigarette smoking. It is also possible that mortality outcomes of diseases with common risk factors are too crude a measure for comparison of the etiologic mechanisms or that the same risk factor has a variable latency period between exposure and outcome.
We have found different secular IHD mortality trends in the southeastern states and other states, both in terms of the time and magnitude of the decline. These differences have important epidemiologic implications because they suggest that the declines in mortality may not be due to revolutionary changes, either in lifestyle or in medical care, that occurred at one time, but are rather due to a series of changes that took place at various times in different regions. These findings also have important public health implications because the more substantial declines in IHD mortality in the three other selected states contributed to greater declines in both overall CVD mortality and rates of death from all causes. IHD remains the leading cause of death in this country, and among the seven states studied, those with higher IHD rates have a higher death rates from all causes. Therefore, any change in IHD mortality rates would have an impact on the overall mortality in the U. S. population.
